Ernexa Therapeutics Inc. (ERNA) Short Interest
Nasdaq • ERNA • US1140824079
As of Oct 27, 2026, ORTEX estimated 2% of free float sold short, 0.4 days to cover, cost to borrow 23.65%. Sign up for live short interest data.
Nasdaq • ERNA • US1140824079
As of Oct 27, 2026, ORTEX estimated 2% of free float sold short, 0.4 days to cover, cost to borrow 23.65%. Sign up for live short interest data.
This page tracks how heavily Ernexa Therapeutics Inc. (Nasdaq:ERNA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Ernexa Therapeutics Inc. (Nasdaq: ERNA) has a market capitalization of $3.15M. Last close $1.93 (as of 2026-11-12); 52-week range $1.74 to $41.75. ORTEX data as of 2026-10-27: short interest was 2% of free float, 0.4 days to cover and the average cost to borrow was 23.65%. Sign up for live short interest data.